Omega-3 polyunsaturated fatty acids for non-alcoholic fatty liver disease

To evaluate the beneficial and harmful effects of omega-3 polyunsaturated fatty acids supplementation in people with non-alcoholic fatty liver disease.

This is a protocol.

You may also be interested in:

No evidence to support or refute the effect of bile acids in patients with non-alcoholic fatty liver disease and/or steatohepatitis
No evidence to support or refute antioxidant supplements for patients with non-alcoholic fatty liver disease and/or steatohepatitis
No evidence to support or refute probiotics for patients with non-alcoholic fatty liver disease and/or steatohepatitis
Weight reduction for non-alcoholic fatty liver disease
Statins for non-alcoholic steatohepatitis

Health topics:

Gastroenterology & hepatology > Liver disorders > Fatty liver

Published:

20 November 2013

Authors:

Lin S, Xiao K, Liu Y, Su P, Chen P, Zhang Y, Bai Y

Primary Review Group:

Hepato-Biliary Group

See the full Review on

the Cochrane Library

Print
PDF
Citation
Lin S, Xiao K, Liu Y, Su P, Chen P, Zhang Y, Bai Y. Omega-3 polyunsaturated fatty acids for non-alcoholic fatty liver disease. Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD010838. DOI: 10.1002/14651858.CD010838